Meeting Banner
Abstract #2587

Quantitative T1 and T2 measurements of metastatic bone lesions in prostate cancer patients: MR fingerprinting versus standard quantitative MRI

Mihaela Rata1,2, Nina Tunariu1,2, Yun Jiang3, Julie Hughes1, Georgina Hopkinson1, Erica Scurr1, Jessica M Winfield1,2, Vikas Gulani3, Dow-Mu Koh1,2, and Matthew R Orton1,2
1Radiology/MRI Unit, Royal Marsden NHS Foundation Trust, Sutton/London, United Kingdom, 2Division of Radiotherapy and Imaging, Institute of Cancer Research, Sutton/London, United Kingdom, 3Radiology, University of Michigan, Ann Arbor, MI, United States

Synopsis

Magnetic resonance fingerprinting (MRF) generates fast, co-registered quantitative maps from a single acquisition. This prospective study evaluates MRF-derived measures of treatment-induced T1 and T2 changes in prostate cancer patients with metastatic bone disease, by comparison with existing quantitative T1 and T2 measurements. This study demonstrated a good correlation of MRF-derived T1 and T2 changes with existing quantitative methods, supporting the use of MRF for faster measurements in bone lesions.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Abstract Presentation Video

Keywords